Timothy Daley
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
58
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $45 | $43.08 | +5.20% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $17.99 | +11.17% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $121.04 | -21.51% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $59.29 | +21.44% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $136.87 | +5.94% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,342.09 | -3.14% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $387.21 | -26.40% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $247.76 | -0.31% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $180.96 | +51.97% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $227.10 | +18.89% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $14.44 | +93.91% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $19.59 | +78.66% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $557.92 | -6.80% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $1.78 | +405.62% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $138.61 | +33.47% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $82.33 | +3.24% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $209.16 | +5.18% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $220.40 | -0.18% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $22.31 | +25.50% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $155.29 | -9.85% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $75.31 | +19.51% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $45
Current: $43.08
Upside: +5.20%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $17.99
Upside: +11.17%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $121.04
Upside: -21.51%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $59.29
Upside: +21.44%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $136.87
Upside: +5.94%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,342.09
Upside: -3.14%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $387.21
Upside: -26.40%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $247.76
Upside: -0.31%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $180.96
Upside: +51.97%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $227.10
Upside: +18.89%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $14.44
Upside: +93.91%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $19.59
Upside: +78.66%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $557.92
Upside: -6.80%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $1.78
Upside: +405.62%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $138.61
Upside: +33.47%
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $82.33
Upside: +3.24%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $209.16
Upside: +5.18%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $220.40
Upside: -0.18%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $22.31
Upside: +25.50%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $155.29
Upside: -9.85%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $75.31
Upside: +19.51%